Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Bloomsbury shares spark on 2027 profit outlook
(Sharecast News) - Shares in Bloomsbury Publishing shot higher on Thursday after it said profit for the year ending 28 February 2027 was set to be "materially ahead" of market expectations as Sarah J. Maas will publish her next two novels within the next year. Bloomsbury noted in an update that Sarah J. Maas will publish the next two novels in her A Court of Thorns and Roses (ACOTAR) series on 27 October 2026 and 12 January 2027.
Chief executive Nigel Newton said: "Fans all over the world are eagerly anticipating reading the next books in the ACOTAR series and we are very excited about this news. Publishing two novels within 11 weeks of each other from a bestselling author is almost unprecedented in publishing history."
Bloomsbury expects group profit for the year ended 28 February 2026 to be in line with consensus expectations of £44.3m. "This reflects the benefits of Bloomsbury's portfolio of portfolios strategy and includes a strong performance from the Academic division," it said.
For the year ending 28 February 2027, however, profit is now expected to be materially ahead of consensus expectations of £44.5m.
Bloomsbury pointed out that Sarah J. Maas was the highest selling author in the US in 2024 according to Circana sales data. She was also the No.1 bestselling fantasy author in the UK in 2025.
All 16 of her previous novels are published by Bloomsbury.
At 1025 GMT, the shares were up 16.3% at 552.75p.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
